How do stem cells treat liver disease?

MSCs home to damaged liver tissue where they reduce inflammation, reverse fibrosis, stimulate hepatocyte regeneration, and modulate the immune response. This helps restore liver architecture and function.

Can stem cell therapy treat liver cirrhosis?

MSC therapy has shown significant promise for liver cirrhosis. Clinical studies report improvements in MELD scores, albumin levels, and liver function tests. While not reversing all damage, MSCs can significantly improve liver function.

What liver conditions respond to stem cell therapy?

We treat alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), liver cirrhosis, liver fibrosis, and hepatitis-related liver damage. Each condition receives a tailored treatment protocol.

How long does it take to see liver improvements?

Improvements in liver function tests (ALT, AST, albumin, bilirubin) are typically observed within 1-3 months. Fibrosis reduction and structural improvements may take 3-6 months to become apparent on imaging.

Stem Cell Therapy for Liver Disease (2026 Research)

Research findings on mesenchymal stem cell therapy for liver diseases including cirrhosis, fatty liver (NAFLD), liver fibrosis, and hepatitis-related damage. How MSC treatment repairs liver tissue, reduces fibrosis, and restores hepatic function at StemCell Longevita Istanbul, Turkey.

How MSCs Help Liver Disease

Liver disease progression (from fatty liver → fibrosis → cirrhosis → liver failure) is driven by chronic inflammation and hepatic stellate cell activation. MSCs combat this through multiple mechanisms: suppressing stellate cell activation, promoting collagen degradation, reducing inflammatory cytokines, and providing hepatotrophic growth factors that support hepatocyte regeneration.

Clinical Results in Liver Disease

Published clinical trials in liver cirrhosis patients show improvements in MELD scores, Child-Pugh scores, serum albumin, bilirubin, and FibroScan measurements after MSC therapy. Some patients with end-stage cirrhosis achieve meaningful functional improvement, potentially delaying the need for liver transplantation.

Treatment Delivery for Liver Conditions

Liver patients may receive systemic IV MSC infusion for mild-to-moderate disease, or targeted hepatic artery delivery (via catheterization) for advanced fibrosis or cirrhosis to maximize cell concentration at the target organ. Pre-treatment includes liver function tests, FibroScan/fibronosis staging, and hepatologist consultation.

Frequently Asked Questions

How do stem cells treat liver disease?: MSCs home to damaged liver tissue where they reduce inflammation, reverse fibrosis, stimulate hepatocyte regeneration, and modulate the immune response. This helps restore liver architecture and function.
Can stem cell therapy treat liver cirrhosis?: MSC therapy has shown significant promise for liver cirrhosis. Clinical studies report improvements in MELD scores, albumin levels, and liver function tests. While not reversing all damage, MSCs can significantly improve liver function.
What liver conditions respond to stem cell therapy?: We treat alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), liver cirrhosis, liver fibrosis, and hepatitis-related liver damage. Each condition receives a tailored treatment protocol.
How long does it take to see liver improvements?: Improvements in liver function tests (ALT, AST, albumin, bilirubin) are typically observed within 1-3 months. Fibrosis reduction and structural improvements may take 3-6 months to become apparent on imaging.

Part of Our Liver & Metabolic Conditions Content Cluster

Liver & Metabolic Conditions — Treatment Cluster

Pillar: stem cell therapy for liver disease in Istanbul

Research & guides: MSC therapy for diabetes management in Turkey | stem cell treatment for liver cirrhosis and fibrosis in Istanbul